// App-Quantinova.ai

1087 : Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype.

Researchers

Presenter

  • Sayaka Kuba

Principal Investigators

  • Mayumi Ishida

  • Shigeki Minami

  • Susumu Eguchi

  • Shinji Ohno

  • Yoshiaki Nakamura

  • Kenji Taguchi

  • Kosho Yamanouchi

Medical Centers

  • Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan

  • Department of Clinical Oncology, National Kyushu Cancer Center, Fukuoka, JapanDepartment of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, JapanDepartment of Pathology, National Kyushu Cancer Center, Fukuoka, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Brain metastasis

  • Breast cancer

  • Solid malignancies

  • Triple-negative breast cancer

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved